Published in Circulation on February 01, 1982
Electrophysiological action of bepridil on atrioventricular accessory pathways. Br Heart J (1987) 0.83
Current management of the Wolff-Parkinson-White syndrome. West J Med (1990) 0.82
Impact of transesophageal electrophysiologic study to elucidate the mechanism of arrhythmia on children with supraventricular tachycardia and no preexcitation. Pediatr Cardiol (2013) 0.81
Transesophageal electrocardiography and adenosine in the diagnosis of wide complex tachycardia. Tex Heart Inst J (1994) 0.80
Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome. Br Heart J (1993) 0.78
Efficacy of sotalol in controlling reentrant supraventricular tachycardias. Cardiovasc Drugs Ther (1990) 0.77
Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ (1989) 4.76
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med (2000) 3.32
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation (1995) 2.88
Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation (2001) 2.49
Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med (1979) 2.20
List-mode maximum-likelihood reconstruction applied to positron emission mammography (PEM) with irregular sampling. IEEE Trans Med Imaging (2000) 2.13
Xylazine hydrochloridine (Rompun) overdose in man. Clin Toxicol (1979) 2.00
Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation (1999) 1.99
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart (2004) 1.77
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther (1977) 1.77
The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. N Engl J Med (1989) 1.72
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation (1990) 1.70
Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. Br J Clin Pharmacol (1984) 1.66
How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med (1996) 1.62
Malposition of transvenous pacing lead in the left ventricle: radiographic findings. AJR Am J Roentgenol (1994) 1.59
A prospective study of elective stenting in unprotected left main coronary disease. Catheter Cardiovasc Interv (1999) 1.55
Technetium pyrophosphate scanning in the detection of acute myocardial infarction: clinical experience. Can Med Assoc J (1977) 1.55
Feasibility of long-term electrocardiographic monitoring with an implanted device for syncope diagnosis. Pacing Clin Electrophysiol (1990) 1.54
Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation (2000) 1.51
The nodoventricular Mahaim pathway: an endangered concept? Circulation (1994) 1.47
Feasibility of direct discharge from the coronary/intermediate care unit after acute myocardial infarction. J Am Coll Cardiol (1999) 1.47
Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy? Circulation (1983) 1.47
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol (1990) 1.46
Right ventricular pressure during ventricular arrhythmias in humans: potential implications for implantable antitachycardia devices. J Am Coll Cardiol (1990) 1.41
Surgical epicardial ablation of left ventricular pathway using sling exposure. Ann Thorac Surg (1990) 1.40
Results of operative therapy in the permanent form of junctional reciprocating tachycardia. Am J Cardiol (1989) 1.39
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem (1983) 1.38
The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation (1995) 1.36
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology (2009) 1.30
The salvage of infected cardiac pacemaker pockets using a closed irrigation system. Pacing Clin Electrophysiol (1986) 1.30
Intermittent preexcitation in the Wolff-Parkinson-White syndrome. Am J Cardiol (1983) 1.25
Effect of dual atrioventricular node pathways on atrioventricular reentrant tachycardia. Circulation (1995) 1.25
Variability in prescription drug utilization: issues for research. CMAJ (1996) 1.24
Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation (1985) 1.21
Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility. Am J Med (1990) 1.19
Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol (2001) 1.19
Characteristics of accessory pathways exhibiting decremental conduction. Am J Cardiol (1991) 1.15
Quinidine-rifampin interaction. N Engl J Med (1981) 1.14
The coronary sinus diverticulum: a pathologic entity associated with the Wolff-Parkinson-White syndrome. Am J Cardiol (1988) 1.14
Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med (1982) 1.14
Measurement of partial agonist activity of pindolol. Clin Pharmacol Ther (1981) 1.13
Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol (1998) 1.13
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
Malposition of transvenous pacing lead in the left ventricle. Pacing Clin Electrophysiol (1993) 1.13
Phenytoin-theophylline interaction. N Engl J Med (1982) 1.10
Anatomic substrate for idiopathic left ventricular tachycardia. Circulation (1996) 1.09
Closed-heart technique for Wolff-Parkinson-White syndrome: further experience and potential limitations. Ann Thorac Surg (1986) 1.09
Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology (1988) 1.08
Cardiac dose-response relationships of oral and intravenous pindolol. Br J Clin Pharmacol (1982) 1.08
Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. Circulation (1983) 1.07
Mechanism of 'inappropriate' sinus tachycardia. Role of sympathovagal balance. Circulation (1994) 1.07
Usefulness of noninvasive studies for diagnosis of right ventricular dysplasia. Am J Cardiol (1986) 1.05
Prediction of defibrillation success from a single defibrillation threshold measurement with sequential pulses and two current pathways in humans. Circulation (1988) 1.04
Junctional tachycardia: a useful marker during radiofrequency ablation for atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1993) 1.04
Relationships between heart rate and PR interval during physiological and pharmacological interventions. Br J Clin Pharmacol (1987) 1.03
An audit of requests for therapeutic drug monitoring of digoxin: problems and pitfalls. Ther Drug Monit (1983) 1.03
Cryosurgical ablation of the atrioventricular node-His bundle: long-term follow-up and properties of the junctional pacemaker. Circulation (1980) 1.02
Reaction of the myocardium to cryosurgery: electrophysiology and arrhythmogenic potential. Circulation (1979) 1.01
The high cost of syncope: cost implications of a new insertable loop recorder in the investigation of recurrent syncope. Am Heart J (1999) 1.01
Grapefruit juice--felodipine interaction in the elderly. Clin Pharmacol Ther (2000) 1.01
Severe coughing during captopril and enalapril therapy. CMAJ (1986) 1.01
Syncope in the Wolff-Parkinson-White syndrome: incidence and electrophysiologic correlates. Pacing Clin Electrophysiol (1984) 1.00
Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity. Clin Pharmacol Ther (1985) 1.00
Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther (1978) 0.99
A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol (1993) 0.99
Clinical predictors of successful implantable cardioverter defibrillator implantation. Am Heart J (1994) 0.99
Persistent left superior vena cava in patients with congenital atrioventricular preexcitation conduction abnormalities. Am Heart J (1981) 0.99
Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response? Circulation (1992) 0.98
Low energy countershock using an intravascular catheter in an acute cardiac care setting. Am J Cardiol (1982) 0.98
A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med (1984) 0.97
Acute myocardial infarction: thrombotic complications of nephrotic syndrome. Can J Cardiol (1987) 0.97
Tolerance and cardiovascular effects of single dose felodipine/beta-blocker combinations in healthy subjects. J Cardiovasc Pharmacol (1987) 0.97
Time and frequency domain analyses of heart rate variability during orthostatic stress in patients with neurally mediated syncope. Am J Cardiol (1994) 0.96
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J (2000) 0.96
Demonstration of macroreentry and feasibility of operative therapy in the common type of atrial flutter. Am J Cardiol (1986) 0.95
Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. Am J Cardiol (1987) 0.95
Impaired enzyme induction by rifampicin in the elderly. Br J Clin Pharmacol (1984) 0.95
Activity-sensing, rate-responsive pacing: improvement in myocardial performance with exercise. Pacing Clin Electrophysiol (1985) 0.95
Atrioventricular nodal reentry and dual atrioventricular node physiology in patients undergoing accessory pathway ablation. Am J Cardiol (1990) 0.94
Radiofrequency catheter ablation of accessory pathways: a learning experience. Am J Cardiol (1991) 0.94
Defibrillation shocks produce different effects on Purkinje fibers and ventricular muscle: implications for successful defibrillation, refibrillation and postshock arrhythmia. J Am Coll Cardiol (1993) 0.94
Modification in activity of medullary respiratory-related neurons for vocalization and swallowing. J Neurophysiol (1994) 0.94
A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Stroke (1985) 0.93
Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol (1995) 0.93
Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med (1993) 0.93
Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators. Am J Cardiol (1993) 0.92
Cyclosporin-erythromycin interaction in normal subjects. Br J Clin Pharmacol (1987) 0.92